Vitafoods Insights is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Prove it: The power of clinical trials—report

White-paper-Prove it: The power of clinical trials—report

Prove it: The power of clinical trials—report
In recent years, the need for validated health claims in the form of substantiated science has become somewhat unnegotiable, leading to a considerable increase in the number of businesses investing in clinical trials. More nutraceutical, food and beverage manufacturers involved in the development and commercialisation of their respective products are joining the industry-wide trend through collaboration with research partners that can support clinical investigation and file preparation.


  • The proliferation of clinical data is making it challenging for companies to compete if they lack evidence pertaining to the effects of their products in humans
  • Randomised, double-blind, placebo-controlled trials have emerged as the gold standard of clinical evidence for drugs, nutraceuticals and functional foods, with boundaries blurring as these sectors look to meet the needs of the same consumers, but with different purchasing approaches
  • Companies struggling to find investment for clinical trials can gain practical insights through case studies with research teams or smaller-scale pilot trials
  • CROs and universities are commonly selected as research partners, but there are complex layers that businesses need to consider in their selection process.

Register to access this resource

Registering as a member of Vitafoods Insights will give you free access to premium content including digital magazines, webinars, whitepapers and more.